A detailed history of Amalgamated Bank transactions in Fulgent Genetics, Inc. stock. As of the latest transaction made, Amalgamated Bank holds 5,988 shares of FLGT stock, worth $120,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,988
Previous 5,909 1.34%
Holding current value
$120,538
Previous $116,000 12.07%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

BUY
$19.6 - $25.06 $1,548 - $1,979
79 Added 1.34%
5,988 $130,000
Q2 2024

Aug 12, 2024

SELL
$19.09 - $22.57 $14,947 - $17,672
-783 Reduced 11.7%
5,909 $116,000
Q1 2024

Apr 23, 2024

SELL
$21.55 - $29.29 $7,499 - $10,192
-348 Reduced 4.94%
6,692 $145,000
Q4 2023

Feb 06, 2024

SELL
$23.64 - $30.27 $25,578 - $32,752
-1,082 Reduced 13.32%
7,040 $204,000
Q2 2023

Aug 11, 2023

SELL
$28.52 - $40.7 $8,213 - $11,721
-288 Reduced 3.42%
8,122 $300,000
Q1 2023

May 02, 2023

SELL
$29.39 - $36.27 $22,453 - $27,710
-764 Reduced 8.33%
8,410 $263,000
Q4 2022

Feb 10, 2023

SELL
$29.23 - $40.28 $5,173 - $7,129
-177 Reduced 1.89%
9,174 $273,000
Q3 2022

Nov 09, 2022

BUY
$37.92 - $63.74 $9,290 - $15,616
245 Added 2.69%
9,351 $356,000
Q2 2022

Aug 15, 2022

BUY
$47.98 - $62.75 $4,558 - $5,961
95 Added 1.05%
9,106 $497,000
Q1 2022

Jun 30, 2022

SELL
$49.85 - $96.11 $18,992 - $36,617
-381 Reduced 4.06%
9,011 $562,000
Q4 2021

Feb 15, 2022

SELL
$77.3 - $105.0 $5,101 - $6,930
-66 Reduced 0.7%
9,392 $945,000
Q3 2021

Oct 29, 2021

BUY
$74.87 - $110.87 $21,562 - $31,930
288 Added 3.14%
9,458 $851,000
Q2 2021

Aug 16, 2021

BUY
$66.8 - $100.45 $612,556 - $921,126
9,170 New
9,170 $846,000

Others Institutions Holding FLGT

About Fulgent Genetics, Inc.


  • Ticker FLGT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 30,265,800
  • Market Cap $609M
  • Description
  • Fulgent Genetics, Inc., together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally. The company offers genetic tests comprising Focus and Comprehensive oncology panels tests; Beacon carrier screening panels test for inherited conditions...
More about FLGT
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.